TY - JOUR
T1 - The Power of Plasticity—Metabolic Regulation of Hepatic Stellate Cells
AU - Trivedi, Parth
AU - Wang, Shuang
AU - Friedman, Scott L.
N1 - Funding Information:
This work was supported by grants from the National Institutes of Health (R01DK56621) to S.L.F. the American Gastroenterological Association to S.W. (AGA2020-13-03), and the Mount Sinai, MD/MSCR Patient-Oriented Research Training and Leadership (PORTAL) program to P.T.
Funding Information:
This work was supported by grants from the National Institutes of Health ( R01DK56621 ) to S.L.F., the American Gastroenterological Association to S.W. ( AGA2020-13-03 ), and the Mount Sinai, MD/ MSCR Patient-Oriented Research Training and Leadership (PORTAL) program to P.T.
Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2021/2/2
Y1 - 2021/2/2
N2 - Hepatic stellate cells (HSCs) are resident non-parenchymal liver pericytes whose plasticity enables them to regulate a remarkable range of physiologic and pathologic responses. To support their functions in health and disease, HSCs engage pathways regulating carbohydrate, mitochondrial, lipid, and retinoid homeostasis. In chronic liver injury, HSCs drive hepatic fibrosis and are implicated in inflammation and cancer. To do so, the cells activate, or transdifferentiate, from a quiescent state into proliferative, motile myofibroblasts that secrete extracellular matrix, which demands rapid adaptation to meet a heightened energy need. Adaptations include reprogramming of central carbon metabolism, enhanced mitochondrial number and activity, endoplasmic reticulum stress, and liberation of free fatty acids through autophagy-dependent hydrolysis of retinyl esters that are stored in cytoplasmic droplets. As an archetype for pericytes in other tissues, recognition of the HSC's metabolic drivers and vulnerabilities offer the potential to target these pathways therapeutically to enhance parenchymal growth and modulate repair.
AB - Hepatic stellate cells (HSCs) are resident non-parenchymal liver pericytes whose plasticity enables them to regulate a remarkable range of physiologic and pathologic responses. To support their functions in health and disease, HSCs engage pathways regulating carbohydrate, mitochondrial, lipid, and retinoid homeostasis. In chronic liver injury, HSCs drive hepatic fibrosis and are implicated in inflammation and cancer. To do so, the cells activate, or transdifferentiate, from a quiescent state into proliferative, motile myofibroblasts that secrete extracellular matrix, which demands rapid adaptation to meet a heightened energy need. Adaptations include reprogramming of central carbon metabolism, enhanced mitochondrial number and activity, endoplasmic reticulum stress, and liberation of free fatty acids through autophagy-dependent hydrolysis of retinyl esters that are stored in cytoplasmic droplets. As an archetype for pericytes in other tissues, recognition of the HSC's metabolic drivers and vulnerabilities offer the potential to target these pathways therapeutically to enhance parenchymal growth and modulate repair.
UR - http://www.scopus.com/inward/record.url?scp=85097473825&partnerID=8YFLogxK
U2 - 10.1016/j.cmet.2020.10.026
DO - 10.1016/j.cmet.2020.10.026
M3 - Review article
C2 - 33232666
AN - SCOPUS:85097473825
SN - 1550-4131
VL - 33
SP - 242
EP - 257
JO - Cell Metabolism
JF - Cell Metabolism
IS - 2
ER -